Standard interleukin-2 (IL-2) and interferon-α immunotherapy versus an IL-2 and 4-Epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma

Emanuele Naglieri, Vittorio Gebbia, Ernesto Durini, Giorgio Lelli, Ines Abbate, Francesco Paolo Selvaggi, Pasquale Di Tonno, Giuseppe Colucci

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Standard interleukin-2 (IL-2) and interferon-α immunotherapy versus an IL-2 and 4-Epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences